By Ibis Sanchez-Serrano and Rathnam Chaguturu

Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs agains...

By Dr Jamie Freeman

Base editing is a potentially transformative technology for engineering DNA in cells that has the potential to generate knockouts or correct certai...

By Dr Ross Macdonald

Cell-based therapies are being widely recognised for their potential to treat a variety of medical conditions, but they face major obstacles toward...

By Helen Stewart-Miller and Abby George

'Fail early, fail fast' has been a mantra in the pharmaceutical industry for several years and directly impacts the overall strategy of many drug d...

By Uduak Grace Thomas

In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify can...

By Richard Gray

The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathoge...

By Dr Megan MacBride

The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe.

By Dr Karin Bottcher

High content screening (HCS) has played a significant role in infectious disease research and drug discovery to date and can be a strong tool in th...

By Dr Samantha Zaroff

The pros and cons of different delivery modalities for personalised cancer vaccines.